|
IPSC | Century Therapeutics, Inc. |
|
|
IPSC | Century Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 3.48 |
| Leverage | 54.32% |
| Market Cap | $ 46.4m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -125.8m |
| Margin | -1836.04% |
None